Physician

Ha Nguyen Tran, M.D.

According to 2025 Medicare claims, Ha Tran, M.D. (NPI: 1659558823) practices hematology/oncology in the Atlanta-Sandy Springs-Roswell, GA market, with the plurality of this provider's patient population coming from Henry, GA. This provider's primary affiliated billing organization is PIEDMONT CANCER INSTITUTE PC (NPI: 1336180637; TIN: 581761689) and primary practice location at 30281-9069.

Tran's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 277 traditional Medicare patients, billed 95,259 HCPCS/CPT codes, and received $1,208,441 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,858 prescription claims across 304 beneficiaries totaling $3,451,367 in drug costs, led by Revlimid (Lenalidomide). DME data shows 24 claims. Open Payments data shows 29 records totaling $654. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $489,275 to $3,451,367. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $7,086 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	400	80,170	$974,886
2016	449	113,194	$1,611,979
2017	502	104,196	$1,585,996
2018	508	126,585	$1,773,423
2019	504	158,016	$1,959,227
2020	455	109,634	$1,687,109
2021	453	115,753	$1,422,322
2022	298	83,665	$1,404,854
2023	289	88,570	$1,218,697
2024	277	95,259	$1,208,441

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	178	968	$489,275
2016	235	1,474	$1,357,609
2017	252	1,385	$1,471,969
2018	282	1,776	$1,590,285
2019	293	1,505	$901,309
2020	274	1,509	$1,135,617
2021	301	1,479	$1,593,665
2022	292	1,390	$1,829,628
2023	285	1,750	$2,003,702
2024	304	1,858	$3,451,367

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	90	$6,656
2016	N/R	87	$20,109
2017	N/R	85	$24,180
2018	N/R	125	$17,150
2019	N/R	106	$10,357
2020	N/R	53	$4,840
2021	N/R	90	$7,282
2022	N/R	14	$2,639
2023	N/R	26	$3,447
2024	N/R	24	$2,732

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	98	188	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	126	229	$58
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	37	74	$44
96372	Injection of drug or substance under skin or into muscle	52	262	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	199	540	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	41	1,092	$633,976
Erleada	Apalutamide	35	1,050	$493,051
Verzenio	Abemaciclib	23	644	$347,780
Imbruvica	Ibrutinib	11	308	$179,780
Lenalidomide	Lenalidomide	11	308	$164,568

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4409	Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each	N	N/R	12	$1,461
A4419	Ostomy pouch, closed; for use on barrier with non-locking flange, with filter (2 piece), each	N	N/R	12	$1,271

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$654	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ha Nguyen Tran, M.D.?

Tedicare shows public-source Medicare data for Ha Nguyen Tran, M.D. (NPI 1659558823), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ha Nguyen Tran, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ha Nguyen Tran, M.D.?

Ha Nguyen Tran, M.D. is linked to PIEDMONT CANCER INSTITUTE PC (billing NPI 1336180637) in the available physician profile data.

Does Ha Nguyen Tran, M.D. have Open Payments data?

Ha Nguyen Tran, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.